Literature DB >> 8557634

Protein SIC, a novel extracellular protein of Streptococcus pyogenes interfering with complement function.

P Akesson1, A G Sjöholm, L Björck.   

Abstract

The human pathogen Streptococcus pyogenes possesses a chromosomal region, the mga regulon, that contains co-regulated genes important to the virulence of these bacteria. A novel gene located in the mga regulon of a S. pyogenes strain of serotype M1 was cloned and sequenced. It translates into a protein of 305 amino acid residues, including a signal sequence of 32 amino acids and a central region consisting of three tandem repeats. The sequence represents a novel structure with no significant homology to any previously published sequence. The protein was purified from the streptococcal culture media where it is present in substantial amounts. Affinity chromatography of human plasma on Sepharose coupled with the protein specifically absorbed two plasma proteins which were identified as clusterin and histidine-rich glycoprotein (HRG). The interactions between the streptococcal protein and the plasma proteins were further characterized using purified clusterin and HRG. Inhibition experiments indicated that they have affinity for overlapping or closely located sites in the streptococcal protein. Both clusterin and HRG are regulators of the membrane attack complex (C5b-C9) of complement. When the streptococcal protein was added to serum, complement-mediated lysis of sensitized sheep erythrocytes and guinea pig erythrocytes was inhibited. In addition, the streptococcal protein was incorporated into C5b-C9 in serum, indicating the location of its action. The name, protein SIC, streptococcal inhibitor of complement-mediated lysis, is therefore suggested for this novel protein. The occurrence of protein SIC and its gene was investigated in a collection of S. pyogenes strains comprising 55 different M serotypes. Only M1 and M57 strains were positive in this screening, indicating that protein SIC could be a virulence determinant. Thus, during recent years, the M1 serotype has been connected with a world-wide increase of severe and toxic S. pyogenes infections.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8557634     DOI: 10.1074/jbc.271.2.1081

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  93 in total

1.  BrkA protein of Bordetella pertussis inhibits the classical pathway of complement after C1 deposition.

Authors:  M G Barnes; A A Weiss
Journal:  Infect Immun       Date:  2001-05       Impact factor: 3.441

Review 2.  Group A Streptococcus: allelic variation, population genetics, and host-pathogen interactions.

Authors:  S D Reid; N P Hoe; L M Smoot; J M Musser
Journal:  J Clin Invest       Date:  2001-02       Impact factor: 14.808

3.  Streptococcal inhibitor of complement (SIC) inhibits the membrane attack complex by preventing uptake of C567 onto cell membranes.

Authors:  B A Fernie-King; D J Seilly; C Willers; R Würzner; A Davies; P J Lachmann
Journal:  Immunology       Date:  2001-07       Impact factor: 7.397

Review 4.  Subversion of the innate immune response by micro-organisms.

Authors:  B Fernie-King; D J Seilly; A Davies; P J Lachmann
Journal:  Ann Rheum Dis       Date:  2002-11       Impact factor: 19.103

5.  Genomic location and variation of the gene for CRS, a complement binding protein in the M57 strains of Streptococcus pyogenes.

Authors:  Michael Binks; David McMillan; Kadaba S Sriprakash
Journal:  Infect Immun       Date:  2003-12       Impact factor: 3.441

6.  Genetic switch to hypervirulence reduces colonization phenotypes of the globally disseminated group A streptococcus M1T1 clone.

Authors:  Andrew Hollands; Morgan A Pence; Anjuli M Timmer; Sarah R Osvath; Lynne Turnbull; Cynthia B Whitchurch; Mark J Walker; Victor Nizet
Journal:  J Infect Dis       Date:  2010-07-01       Impact factor: 5.226

7.  Nonpolar inactivation of the hypervariable streptococcal inhibitor of complement gene (sic) in serotype M1 Streptococcus pyogenes significantly decreases mouse mucosal colonization.

Authors:  S Lukomski; N P Hoe; I Abdi; J Rurangirwa; P Kordari; M Liu; S J Dou; G G Adams; J M Musser
Journal:  Infect Immun       Date:  2000-02       Impact factor: 3.441

8.  Genetic characterization and virulence role of the RALP3/LSA locus upstream of the streptolysin s operon in invasive M1T1 Group A Streptococcus.

Authors:  Laura A Kwinn; Arya Khosravi; Ramy K Aziz; Anjuli M Timmer; Kelly S Doran; Malak Kotb; Victor Nizet
Journal:  J Bacteriol       Date:  2006-11-17       Impact factor: 3.490

9.  DRS is far less divergent than streptococcal inhibitor of complement of group A streptococcus.

Authors:  Vivek Sagar; Rajesh Kumar; Nirmal K Ganguly; Thangam Menon; Anuradha Chakraborti
Journal:  J Bacteriol       Date:  2007-01-19       Impact factor: 3.490

10.  Effect of antibiotics on group A Streptococcus exoprotein production analyzed by two-dimensional gel electrophoresis.

Authors:  Megumi Tanaka; Tadao Hasegawa; Akira Okamoto; Keizo Torii; Michio Ohta
Journal:  Antimicrob Agents Chemother       Date:  2005-01       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.